HI
VRTX icon

Harbour Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Harbour Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Sell
734
-154
-17% -$68.3K ﹤0.01% 1281
2026
Q1 		$397K Buy
888
+395
+80% +$184K 0.01% 1164
2025
Q4 		$224K Buy
493
+29
+6% +$12.5K ﹤0.01% 1225
2025
Q3 		$182K Buy
464
+61
+15% +$25.5K ﹤0.01% 1282
2025
Q2 		$179K Sell
403
-7
-2% -$3.23K ﹤0.01% 1224
2025
Q1 		$199K Buy
410
+68
+20% +$31.7K 0.01% 1100
2024
Q4 		$138K Buy
342
+1
+0.3% +$464 ﹤0.01% 1205
2024
Q3 		$159K Sell
341
-44
-11% -$21.1K ﹤0.01% 1115
2024
Q2 		$180K Buy
385
+15
+4% +$6.51K 0.01% 988
2024
Q1 		$155K Buy
370
+57
+18% +$24.1K 0.01% 1023
2023
Q4 		$127K Buy
313
+51
+19% +$18.8K 0.01% 1040
2023
Q3 		$91.1K Sell
262
-13
-5% -$4.55K ﹤0.01% 1087
2023
Q2 		$96.8K Buy
275
+6
+2% +$2.02K ﹤0.01% 1074
2023
Q1 		$84.8K Sell
269
-65
-19% -$19.5K ﹤0.01% 1116
2022
Q4 		$96.5K Buy
334
+45
+16% +$13.7K 0.01% 1019
2022
Q3 		$81K Hold
289
– – 0.01% 1066
2022
Q2 		$81K Buy
+289
New +$77.4K 0.01% 1066
2021
Q4 		$98K Sell
444
-838
-65% -$163K 0.01% 976
2021
Q3 		$233K Buy
1,282
+148
+13% +$28.9K 0.01% 947
2021
Q2 		$229K Buy
1,134
+102
+10% +$21.3K 0.01% 981
2021
Q1 		$222K Buy
+1,032
New +$227K 0.01% 918

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harbour Investments's VRTX Position: Q2 2026 in Review

Harbour Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, selling an estimated $68.3K and leaving 734 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

Harbour Investments first reported a position in VRTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $397K in Q1 2026. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Harbour Investments held 734 shares of Vertex Pharmaceuticals worth $365K as of Q2 2026.
  • Harbour Investments sold 154 Vertex Pharmaceuticals shares in Q2 2026, an estimated $68.3K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1281 holding.
  • Harbour Investments first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Vertex Pharmaceuticals position peaked at $397K in Q1 2026.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.